Literature DB >> 25694765

Eosinophilic ascites, as a rare presentation of eosinophilic gastroenteritis.

L Cuko1, F Bilaj1, B Bega1, A Barbullushi1, B Resuli1.   

Abstract

BACKGROUND: Eosinophilic ascites is the most unusual presentation of eosinophilic gastroenteritis (EGE), caused by edema and eosinophilic inflammation of the small bowel wall's serosal layer. CASE REPORT: We report the case of a 37-year-old woman, who presented with diffuse abdominal pain, nausea, abdominal distension, moderate ascites and diarrhea of two weeks duration. The rest of physical and clinical examination was unremarkable, and her past medical history was uneventful. Magnetic Resonance Imaging showed the presence of ascites and diffuse thickening of small bowel wall, but did not detect a primary malignancy in the abdominal cavity; and no signs of portal hypertension or liver damage. Laboratory test results revealed essential peripheral blood eosinophilia, elevated serum IgE and marked increase of eosinophils in the abdominal fluid. Treatment with corticosteroids normalized laboratory tests results, and the ascites resolved immediately.
CONCLUSIONS: EGE is a rare entity and it should be kept in mind in patients of unexplained ascites. The absence of primary malignancy on imaging, coupled with marked increase of fluid esinophilia and immediate response to treatment with steroids, confirm indirectly the diagnosis of EGE. Hippokratia 2014; 18 (3): 275-277.

Entities:  

Keywords:  Eosinophilic gastroenteritis; ascites; corticosteroids; magnetic resonance imaging

Year:  2014        PMID: 25694765      PMCID: PMC4309151     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  10 in total

1.  Leukotriene receptor antagonists as potential steroid sparing agents in a patient with serosal eosinophilic gastroenteritis.

Authors:  M C Urek; M Kujundzić; M Banić; R Urek; T S Veic; D Kardum
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

2.  Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.

Authors:  N J Talley; R G Shorter; S F Phillips; A R Zinsmeister
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 3.  Eosinophilic gastroenteritis.

Authors:  Seema Khan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-04       Impact factor: 3.043

Review 4.  The hypereosinophilic syndromes: still more heterogeneity.

Authors:  Gerald J Gleich; Kristin M Leiferman
Journal:  Curr Opin Immunol       Date:  2005-10-07       Impact factor: 7.486

5.  Eosinophilic ascites, an unusual presentation of eosinophilic gastroenteritis: A case report and review.

Authors:  Iryna S Hepburn; Subbaramiah Sridhar; Robert R Schade
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

6.  Eosinophilic gastroenteritis with ascites and hepatic dysfunction.

Authors:  Hai-Bo Zhou; Jin-Ming Chen; Qin Du
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

7.  [Eosinophilic gastroenteritis. A case with predominant involvement of mucosal and muscular layers].

Authors:  A Agostino; A Parenzi
Journal:  Minerva Med       Date:  1994-12       Impact factor: 4.806

Review 8.  Eosinophils and allergic diseases of the gastrointestinal tract.

Authors:  Stephan C Bischoff; Friedericke A Ulmer
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 9.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

10.  [Eosinophilic enteritis as a rare cause of ascites].

Authors:  A Bouhmidi; R Lorente Poyatos; P Romero Cara; J J Ibáñez Martín; F Casado Caballero; D Quintero Fuientes; J L Martín Ruiz
Journal:  Gastroenterol Hepatol       Date:  2003-10       Impact factor: 2.102

  10 in total
  1 in total

1.  Eosinophilic ascites: A case report and literature review.

Authors:  Raed M Alsulaiman
Journal:  J Family Community Med       Date:  2015 Sep-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.